461 related articles for article (PubMed ID: 30041013)
61. A lipoprotein receptor cluster IV mutant preferentially binds amyloid-β and regulates its clearance from the mouse brain.
Sagare AP; Bell RD; Srivastava A; Sengillo JD; Singh I; Nishida Y; Chow N; Zlokovic BV
J Biol Chem; 2013 May; 288(21):15154-66. PubMed ID: 23580652
[TBL] [Abstract][Full Text] [Related]
62. Lipopolysaccharide alters the blood-brain barrier transport of amyloid beta protein: a mechanism for inflammation in the progression of Alzheimer's disease.
Jaeger LB; Dohgu S; Sultana R; Lynch JL; Owen JB; Erickson MA; Shah GN; Price TO; Fleegal-Demotta MA; Butterfield DA; Banks WA
Brain Behav Immun; 2009 May; 23(4):507-17. PubMed ID: 19486646
[TBL] [Abstract][Full Text] [Related]
63. Local perfusion of capillaries reveals disrupted beta-amyloid homeostasis at the blood-brain barrier in Tg2576 murine Alzheimer's model.
Hanafy AS; Lamprecht A; Dietrich D
Fluids Barriers CNS; 2023 Nov; 20(1):85. PubMed ID: 37993886
[TBL] [Abstract][Full Text] [Related]
64. P-glycoprotein deficiency at the blood-brain barrier increases amyloid-beta deposition in an Alzheimer disease mouse model.
Cirrito JR; Deane R; Fagan AM; Spinner ML; Parsadanian M; Finn MB; Jiang H; Prior JL; Sagare A; Bales KR; Paul SM; Zlokovic BV; Piwnica-Worms D; Holtzman DM
J Clin Invest; 2005 Nov; 115(11):3285-90. PubMed ID: 16239972
[TBL] [Abstract][Full Text] [Related]
65. Endothelial LRP1 - A Potential Target for the Treatment of Alzheimer's Disease : Theme: Drug Discovery, Development and Delivery in Alzheimer's Disease Guest Editor: Davide Brambilla.
Storck SE; Pietrzik CU
Pharm Res; 2017 Dec; 34(12):2637-2651. PubMed ID: 28948494
[TBL] [Abstract][Full Text] [Related]
66. Transport of Alzheimer's associated amyloid-β catalyzed by P-glycoprotein.
McCormick JW; Ammerman L; Chen G; Vogel PD; Wise JG
PLoS One; 2021; 16(4):e0250371. PubMed ID: 33901197
[TBL] [Abstract][Full Text] [Related]
67. Reduction of brain beta-amyloid (Abeta) by fluvastatin, a hydroxymethylglutaryl-CoA reductase inhibitor, through increase in degradation of amyloid precursor protein C-terminal fragments (APP-CTFs) and Abeta clearance.
Shinohara M; Sato N; Kurinami H; Takeuchi D; Takeda S; Shimamura M; Yamashita T; Uchiyama Y; Rakugi H; Morishita R
J Biol Chem; 2010 Jul; 285(29):22091-102. PubMed ID: 20472556
[TBL] [Abstract][Full Text] [Related]
68. Astaxanthin exerts protective effects similar to bexarotene in Alzheimer's disease by modulating amyloid-beta and cholesterol homeostasis in blood-brain barrier endothelial cells.
Fanaee-Danesh E; Gali CC; Tadic J; Zandl-Lang M; Carmen Kober A; Agujetas VR; de Dios C; Tam-Amersdorfer C; Stracke A; Albrecher NM; Manavalan APC; Reiter M; Sun Y; Colell A; Madeo F; Malle E; Panzenboeck U
Biochim Biophys Acta Mol Basis Dis; 2019 Sep; 1865(9):2224-2245. PubMed ID: 31055081
[TBL] [Abstract][Full Text] [Related]
69. Cellular prion protein participates in amyloid-β transcytosis across the blood-brain barrier.
Pflanzner T; Petsch B; André-Dohmen B; Müller-Schiffmann A; Tschickardt S; Weggen S; Stitz L; Korth C; Pietrzik CU
J Cereb Blood Flow Metab; 2012 Apr; 32(4):628-32. PubMed ID: 22293988
[TBL] [Abstract][Full Text] [Related]
70. Clearance of amyloid-beta peptide across the blood-brain barrier: implication for therapies in Alzheimer's disease.
Deane R; Bell RD; Sagare A; Zlokovic BV
CNS Neurol Disord Drug Targets; 2009 Mar; 8(1):16-30. PubMed ID: 19275634
[TBL] [Abstract][Full Text] [Related]
71. Evidence against a role of P-glycoprotein in the clearance of the Alzheimer's disease Aβ1-42 peptides.
Bello I; Salerno M
Cell Stress Chaperones; 2015 May; 20(3):421-30. PubMed ID: 25591827
[TBL] [Abstract][Full Text] [Related]
72. Age dependency of cerebral P-glycoprotein function in wild-type and APPPS1 mice measured with PET.
Zoufal V; Wanek T; Krohn M; Mairinger S; Filip T; Sauberer M; Stanek J; Pekar T; Bauer M; Pahnke J; Langer O
J Cereb Blood Flow Metab; 2020 Jan; 40(1):150-162. PubMed ID: 30354871
[TBL] [Abstract][Full Text] [Related]
73. APOE4-mediated amyloid-β pathology depends on its neuronal receptor LRP1.
Tachibana M; Holm ML; Liu CC; Shinohara M; Aikawa T; Oue H; Yamazaki Y; Martens YA; Murray ME; Sullivan PM; Weyer K; Glerup S; Dickson DW; Bu G; Kanekiyo T
J Clin Invest; 2019 Mar; 129(3):1272-1277. PubMed ID: 30741718
[TBL] [Abstract][Full Text] [Related]
74. Apolipoprotein E increases cell association of amyloid-β 40 through heparan sulfate and LRP1 dependent pathways.
O'Callaghan P; Noborn F; Sehlin D; Li JP; Lannfelt L; Lindahl U; Zhang X
Amyloid; 2014 Jun; 21(2):76-87. PubMed ID: 24491019
[TBL] [Abstract][Full Text] [Related]
75. Brain Distribution of Dual ABCB1/ABCG2 Substrates Is Unaltered in a Beta-Amyloidosis Mouse Model.
Wanek T; Zoufal V; Brackhan M; Krohn M; Mairinger S; Filip T; Sauberer M; Stanek J; Pekar T; Pahnke J; Langer O
Int J Mol Sci; 2020 Nov; 21(21):. PubMed ID: 33153231
[TBL] [Abstract][Full Text] [Related]
76. The role of choroid plexus in IVIG-induced beta-amyloid clearance.
Gu H; Zhong Z; Jiang W; Du E; Dodel R; Farlow MR; Zheng W; Du Y
Neuroscience; 2014 Jun; 270():168-176. PubMed ID: 24747018
[TBL] [Abstract][Full Text] [Related]
77. Imaging P-Glycoprotein Induction at the Blood-Brain Barrier of a β-Amyloidosis Mouse Model with
Zoufal V; Mairinger S; Brackhan M; Krohn M; Filip T; Sauberer M; Stanek J; Wanek T; Tournier N; Bauer M; Pahnke J; Langer O
J Nucl Med; 2020 Jul; 61(7):1050-1057. PubMed ID: 31806767
[TBL] [Abstract][Full Text] [Related]
78. Downregulation of LRP1 [correction of LPR1] at the blood-brain barrier in streptozotocin-induced diabetic mice.
Hong H; Liu LP; Liao JM; Wang TS; Ye FY; Wu J; Wang YY; Wang Y; Li YQ; Long Y; Xia YZ
Neuropharmacology; 2009; 56(6-7):1054-9. PubMed ID: 19285094
[TBL] [Abstract][Full Text] [Related]
79. A multifaceted role for apoE in the clearance of beta-amyloid across the blood-brain barrier.
Bachmeier C; Paris D; Beaulieu-Abdelahad D; Mouzon B; Mullan M; Crawford F
Neurodegener Dis; 2013; 11(1):13-21. PubMed ID: 22572854
[TBL] [Abstract][Full Text] [Related]
80. Low-density lipoprotein receptor-related protein 1 (LRP1) mediates neuronal Abeta42 uptake and lysosomal trafficking.
Fuentealba RA; Liu Q; Zhang J; Kanekiyo T; Hu X; Lee JM; LaDu MJ; Bu G
PLoS One; 2010 Jul; 5(7):e11884. PubMed ID: 20686698
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
